Sonova Holding (OTCMKTS:SONVY) Sees Large Increase in Short Interest

Sonova Holding (OTCMKTS:SONVY) was the recipient of a large growth in short interest in the month of March. As of March 13th, there was short interest totaling 11,701 shares, a growth of 1,008.0% from the February 26th total of 1,056 shares. Based on an average daily volume of 96,203 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are short sold. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 96,203 shares, the short-interest ratio is currently 0.1 days.

Analyst Ratings Changes

Several analysts have issued reports on the stock. BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Zacks Research raised Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. Finally, Jefferies Financial Group lowered Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Sonova currently has an average rating of “Moderate Buy”.

Sonova Price Performance

Shares of SONVY stock opened at $43.29 on Wednesday. Sonova has a fifty-two week low of $42.26 and a fifty-two week high of $68.76. The stock’s 50-day moving average is $51.58 and its two-hundred day moving average is $52.98. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.